Kanova
Suzhou
About Kanova
Kanova is a biopharmaceutical company that focuses on developing therapeutic antibodies and innovative combination therapies in immuno-oncology and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $30.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2023)
- Website: en.kanovabiopharma.com
- Phone: 010-82176552
Industries & Categories
Biopharma, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kanova-75397 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.